Enrollment is Complete for Trial of Experimental Multiple Myeloma Treatment
mwooten / Pixabay

Enrollment is Complete for Trial of Experimental Multiple Myeloma Treatment

According to a story from BioPortfolio, Celgene Corporation and bluebird bio, Inc., have recently announced that enrollment for a pivotal Phase 2 study testing an experimental therapy for relapsed/refractory multiple…

Continue Reading Enrollment is Complete for Trial of Experimental Multiple Myeloma Treatment
ICYMI: Creator of “SpongeBob SquarePants” Dies After Being Diagnosed With Amyotrophic Lateral Sclerosis
Tabeajaichhalt / Pixabay

ICYMI: Creator of “SpongeBob SquarePants” Dies After Being Diagnosed With Amyotrophic Lateral Sclerosis

According to a story from Buzzfeed News, Stephen Hillenburg, the creator of the smash hit children's cartoon SpongeBob SquarePants has passed away at age 57. Last year, Hillenburg had revealed…

Continue Reading ICYMI: Creator of “SpongeBob SquarePants” Dies After Being Diagnosed With Amyotrophic Lateral Sclerosis
Clinical Trial Testing Experimental Treatment for Pulmonary Arterial Hypertension Begins
qimono / Pixabay

Clinical Trial Testing Experimental Treatment for Pulmonary Arterial Hypertension Begins

According to a story from globenewswire.com, the biopharmaceutical company PhaseBio Pharmaceuticals has recently announced that the first patient has been dosed in a Phase 2b clinical trial of the company's…

Continue Reading Clinical Trial Testing Experimental Treatment for Pulmonary Arterial Hypertension Begins
Single Use Gene Therapy Approved in the EU for Leber’s Congenital Amaurosis
Free-Photos / Pixabay

Single Use Gene Therapy Approved in the EU for Leber’s Congenital Amaurosis

According to a story from pm360online.com, the drug developer Novartis has recently announced that the company's gene therapy Luxturna has gained approval in the EU as a treatment for Leber's…

Continue Reading Single Use Gene Therapy Approved in the EU for Leber’s Congenital Amaurosis
FDA Approves Pfizer’s Acute Myeloid Leukemia Treatment for High-Risk Patients
Source: https://pixabay.com/en/thumb-up-like-sign-hand-ok-good-441938/

FDA Approves Pfizer’s Acute Myeloid Leukemia Treatment for High-Risk Patients

According to a publication from MarketScreener, pharmaceutical titan Pfizer Inc. has gained FDA approval for Daurismo, a once-a-day oral medication designed to be paired with low-dose cytarabine (a type of…

Continue Reading FDA Approves Pfizer’s Acute Myeloid Leukemia Treatment for High-Risk Patients
New Survey Highlights the Prevalence of Neurogenic Orthostatic Hypotension in Parkinson’s Patients
andibreit / Pixabay

New Survey Highlights the Prevalence of Neurogenic Orthostatic Hypotension in Parkinson’s Patients

According to a story from Business Wire, a recent survey has revealed new findings about the frequency of neurogenic orthostatic hypotension (nOH) among Parkinson's disease patients. Around one in five…

Continue Reading New Survey Highlights the Prevalence of Neurogenic Orthostatic Hypotension in Parkinson’s Patients

An Experimental Biopsy Approach Could Improve Diffuse Intrinsic Pontine Glioma Monitoring

According to a story from tgen.org, a team of scientists from the Translational Genomics Research Institute (TGEN) have recently initiated a study that will test the effectiveness of liquid biopsy…

Continue Reading An Experimental Biopsy Approach Could Improve Diffuse Intrinsic Pontine Glioma Monitoring